Akifumi Kuwano

4PUBLICATIONS
1CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillanceCondensed matter imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 24, 2025
Prediction of Hepatocellular Carcinoma After Direct-Acting Antiviral Therapy Using Agile 3+ and End-of-Treatment Alpha-Fetoprotein Levels in Patients With Hepatitis C.

Akifumi Kuwano, Masayoshi Yada, Kosuke Tanaka

|May 03, 2025
Tumor-infiltrating CD8+ T-cell numbers and serum C-reactive protein levels as a prognostic biomarker in hepatocellular carcinoma patients receiving atezolizumab plus bevacizumab.

Akifumi Kuwano, Masayoshi Yada, Kosuke Tanaka

|Feb 28, 2023
Risk factors for loss to follow-up after the start of direct-acting antiviral treatment for hepatitis C virus infection.

Akifumi Kuwano, Masayoshi Yada, Kazuki Kurosaka

|Mar 31, 2021
A case of granulocyte colony-stimulating factor-producing intrahepatic sarcomatoid cholangiocarcinoma.

Akifumi Kuwano, Fumiya Narutomi, Shigehiro Nagasawa

Pageof 1

Frequent Collaborators